# US 2003/0211480 A1 · Molecular interaction assays on a solid surface

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2003/0211480 A1
- Document ID: US20030211480A1
- Status: Published application
- Kind: A1
- Application number: 10/141,611
- Filed: 2002-05-08
- Published: 2003-11-13
- Earliest claimed: 2002-05-08
- Assignees: Gentel Bio Surfaces, Inc.
- Inventors: Bryce P. Nelson; Todd C. Strother
- Web page: https://patentgrep.com/patent/US20030211480A1

## CPC

- C40B 30/04: by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
- B82Y 30/00: Nanotechnology for materials or surface science, e.g. nanocomposites
- G01N 33/6845: {Methods of identifying protein-protein interactions in protein mixtures}
- C40B: COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES (in silico combinatorial libraries of nucleic acids, proteins or peptides G16B35/00; in silico combinatorial chemistry G16C20/60)
- B82Y: SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

The present invention relates to novel methods for the analysis of molecular interactions. In particular, the present invention relates to compositions and methods for molecular interaction assays performed in solution and on solid surfaces. The present invention thus provides improves methods and compositions for the analysis of molecular interactions.

## Claims

### Claim 1

A composition comprising a solid surface, said solid surface comprising arrayed nucleic acids, at least one first protein bound to at least one of said arrayed nucleic acids, and a second protein bound to said first protein.

### Claim 2 (depends on 1)

The composition of claim 1, wherein said arrayed nucleic acids comprise an array of target nucleic acid sequences.

### Claim 3 (depends on 1)

The composition of claim 1, wherein said first protein is a first fusion protein, said first fusion protein comprising a DNA binding domain fused to a first binding partner, wherein said DNA binding domain is capable of binding to said target nucleic acid sequence.

### Claim 4 (depends on 1)

The composition of claim 1, wherein said second protein is a second fusion protein, said second fusion protein comprising an RNA polymerase activation domain fused to a second binding partner, wherein said second binding partner is capable of interacting with said first binding partner.

### Claim 5 (depends on 1)

The composition of claim 1, wherein said solid support is a metal, glass or silicon surface.

### Claim 6 (depends on 5)

The composition of claim 5, wherein said metal surface is deposited on an SPR prism.

### Claim 7 (depends on 1)

The composition of claim 1, wherein said array of target nucleic acid sequences comprises at least 20 distinct nucleic acid sequences.

### Claim 8 (depends on 1)

The composition of claim 1, wherein said array of target nucleic acid sequences comprises at least 50 distinct nucleic acid sequences.

### Claim 9 (depends on 1)

The composition of claim 1, wherein said array of target nucleic acid sequences comprises at least 100 distinct nucleic acid sequences.

### Claim 10 (depends on 1)

The composition of claim 1, wherein said array of target nucleic acid sequences comprises at least 1000 distinct nucleic acid sequences.

### Claim 11 (depends on 3)

The composition of claim 3, further comprising a plurality of first fusion proteins, wherein each of said plurality of fusion proteins comprises a distinct first binding partner.

### Claim 12 (depends on 4)

The composition of claim 4, further comprising a plurality of second fusion proteins, wherein each of said plurality of fusion proteins comprises a distinct second binding partner.

### Claim 13 (depends on 1)

The composition of claim 1, wherein said solid support further comprises a plurality of microfluidic channels.

### Claim 14 (depends on 1)

The composition of claim 1, wherein said sold support further comprises a plurality of etched microchannels.

### Claim 15 (depends on 1)

The composition of claim 1, wherein said first binding partner is selected from the group consisting of a peptide, a polypeptide, a nucleic acid, a carbohydrate, a lipid, and a small molecule.

### Claim 16 (depends on 1)

The composition of claim 1, wherein said second binding partner is selected from the group consisting of a peptide, a polypeptide, a nucleic acid, a carbohydrate, a lipid, and a small molecule.

### Claim 17 (depends on 1)

The composition of claim 1, further comprising an antibody bound to said second protein.

### Claim 18

A composition comprising a solid surface, said solid surface comprising an array of first fusion proteins, wherein each of said first fusion proteins comprises a distinct binding partner, and at least one second protein specifically bound to at least one of said first proteins.

### Claim 19 (depends on 18)

The composition of claim 18, further comprising at least one nucleic acid target sequence bound to said first fusion protein or said second protein.

### Claim 20 (depends on 18)

The composition of claim 18, wherein said first fusion protein comprises a DNA binding domain fused to said first binding partner, wherein said DNA binding domain is capable of binding to said target nucleic acid sequence.

### Claim 21 (depends on 18)

The composition of claim 18, wherein said first fusion protein comprises a transcription activation domain fused to said first binding partner.

### Claim 22 (depends on 18)

The composition of claim 18, wherein said second protein comprises a fusion protein, said second fusion protein comprising an RNA polymerase activation domain fused to a second binding partner, wherein said second binding partner is capable of interacting with said first binding partner.

### Claim 23 (depends on 18)

The composition of claim 18, wherein said second protein comprises a fusion protein, said second fusion protein comprising a DNA binding domain fused to a second binding partner, wherein said second binding partner is capable of interacting with said first binding partner.

### Claim 24 (depends on 18)

The composition of claim 18, wherein said solid support is a metal surface.

### Claim 25 (depends on 24)

The composition of claim 24, wherein said metal surface is deposited on an SPR prism.

### Claim 26 (depends on 18)

The composition of claim 18, wherein said array of first fusion proteins comprises at least 20 distinct first binding partners.

### Claim 27 (depends on 18)

The composition of claim 18, wherein said array of first fusion proteins comprises at least 50 distinct first binding partners.

### Claim 28 (depends on 18)

The composition of claim 18, wherein said array of first fusion proteins comprises at least 100 distinct first binding partners.

### Claim 29 (depends on 18)

The composition of claim 18, wherein said array of first fusion proteins comprises at least 1000 distinct first binding partners.

### Claim 30 (depends on 18)

The composition of claim 18, further comprising a plurality of nucleic acid target sequences, wherein each of said plurality of nucleic acid target sequences comprises a distinct nucleic acid sequence.

### Claim 31 (depends on 18)

The composition of claim 18, further comprising a plurality of second fusion proteins, wherein each of said plurality of fusion proteins comprises a distinct second binding partner.

### Claim 32 (depends on 18)

The composition of claim 18, wherein said solid support further comprises a plurality of microfluidic channels.

### Claim 33 (depends on 18)

The composition of claim 18, wherein said sold support further comprises a plurality of etched microchannels.

### Claim 34 (depends on 18)

The composition of claim 18, wherein said first binding partner is selected from the group consisting of a peptide, a polypeptide, a nucleic acid, a carbohydrate, a lipid and a small molecule.

### Claim 35 (depends on 22)

The composition of claim 22, wherein said second binding partner is selected from the group consisting of a peptide, a polypeptide, a nucleic acid, a carbohydrate, a lipid and a small molecule.

### Claim 36 (depends on 24)

The composition of claim 24, further comprising an antibody bound to said second protein.

### Claim 37

A composition comprising a solid surface comprising a plurality of microfluidic channels, said solid surface comprising arrayed nucleic acids, at least one first protein bound to at least one of said arrayed nucleic acids, and a second protein bound to said first protein.

### Claim 38

A composition comprising a solid surface comprising a plurality of etched microchannels, said solid surface comprising arrayed nucleic acids, at least one first protein bound to at least one of said arrayed nucleic acids, and a second protein bound to said first protein.

### Claim 39

A composition comprising a solid surface, said solid surface comprising arrayed nucleic acids, at least one first protein bound to at least one of said arrayed nucleic acids, a second protein bound to said first protein, and an antibody bound to said second protein.

### Claim 40

A composition comprising a solid surface comprising a plurality of microfluidic channels, said solid surface comprising an array of first fusion proteins, wherein each of said first fusion proteins comprises a distinct binding partner, and at least one second protein specifically bound to at least one of said first proteins.

### Claim 41

A composition comprising a solid surface comprising a plurality of etched microchannels, said solid surface comprising an array of first fusion proteins, wherein each of said first fusion proteins comprises a distinct binding partner, and at least one second protein specifically bound to at least one of said first proteins.

### Claim 42

A composition comprising a solid surface, said solid surface comprising an array of first fusion proteins, wherein each of said first fusion proteins comprises a distinct binding partner, at least one second protein specifically bound to at least one of said first proteins, and an antibody bound to said second protein.

### Claim 43

A composition comprising a solution of target nucleic acids, at least one first fusion bound to at least one of said nucleic acids, and a second fusion protein bound to at least one of said first proteins.

### Claim 44 (depends on 43)

The composition of claim 43, further comprising an RNA transcribed from at least one of said target nucleic acids.

### Claim 45 (depends on 43)

The composition of claim 43, wherein said first fusion protein comprises a DNA binding domain fused to a first binding partner, wherein said DNA binding domain is capable of binding to said target nucleic acid sequence.

### Claim 46 (depends on 43)

The composition of claim 43, wherein said second fusion protein comprises an RNA polymerase activation domain fused to a second binding partner, wherein said second binding partner is capable of interacting with said first binding partner.

### Claim 47

A system for the detection of molecular interactions, comprising
a) a solid support comprising an array of target nucleic acid sequences; and
b) a first fusion protein comprising a DNA binding domain fused to a first binding partner, wherein said DNA binding domain is capable of binding to said target nucleic acid sequence; and
c) a second fusion protein comprising an RNA polymerase activation domain fused to a second binding partner, wherein said second binding partner is capable of interacting with said first binding partner.

### Claim 48 (depends on 47)

The system of claim 47, wherein said solid support is a metal surface.

### Claim 49 (depends on 48)

The system of claim 48, wherein said metal surface is deposited on an SPR prism.

### Claim 50 (depends on 47)

The system of claim 47, wherein said array of target nucleic acid sequences comprises at least 20 distinct nucleic acid sequences.

### Claim 51 (depends on 47)

The system of claim 47, wherein said array of target nucleic acid sequences comprises at least 50 distinct nucleic acid sequences.

### Claim 52 (depends on 47)

The system of claim 47, wherein said array of target nucleic acid sequences comprises at least 100 distinct nucleic acid sequences.

### Claim 53 (depends on 47)

The system of claim 47, wherein said array of target nucleic acid sequences comprises at least 1000 distinct nucleic acid sequences.

### Claim 54 (depends on 47)

The system of claim 47, further comprising a plurality of first fusion proteins, wherein each of said plurality of fusion proteins comprises a distinct first binding partner.

### Claim 55 (depends on 47)

The system of claim 47, further comprising a plurality of second fusion proteins, wherein each of said plurality of fusion proteins comprises a distinct second binding partner.

### Claim 56 (depends on 47)

The system of claim 47, further comprising an antibody capable of specifically binding to said second fusion protein.

### Claim 57 (depends on 47)

The system of claim 47, wherein said solid support further comprises a plurality of microfluidics channels.

### Claim 58 (depends on 47)

The system of claim 47, wherein said solid support further comprises a plurality of etched microchannels.

### Claim 59 (depends on 47)

The system of claim 47, wherein said first binding partner is selected from the group consisting of a peptide, a polypeptide, a nucleic acid, a carbohydrate, a lipid and a small molecule.

### Claim 60 (depends on 47)

The system of claim 47, wherein said second binding partner is selected from the group consisting of a peptide, a polypeptide, a nucleic acid, a carbohydrate, a lipid, and a small molecule.

### Claim 61 (depends on 47)

The system of claim 47, further comprising at least one test compound.

### Claim 62 (depends on 61)

The system of claim 61, wherein said test compound is a drug.

### Claim 63 (depends on 47)

The system of claim 47, further comprising an apparatus capable of detecting an interaction between said first fusion protein, and said second fusion protein.

### Claim 64

A system for the detection of molecular interactions, comprising
a) a solid support comprising an array of a first fusion proteins, wherein each of said first fusion proteins comprises a DNA binding domain fused to a first binding partner;
b) a second fusion protein comprising an RNA polymerase activation domain fused to a second binding partner, wherein said second binding partner is capable of interacting with said first binding partner; and
c) at least one target nucleic acid sequence wherein said target sequence is capable of being bound by said DNA binding domain.

### Claim 65

A system for the detection of molecular interactions, comprising
a) a solid support comprising an array of microfluidic channels, said sold support further comprising an array of target nucleic acid sequences; and
b) a first fusion protein comprising a DNA binding domain fused to a first binding partner, wherein said DNA binding domain is capable of binding to said target nucleic acid sequence; and
c) a second fusion protein comprising an RNA polymerase activation domain fused to a second binding partner, wherein said second binding partner is capable of interacting with said first binding partner.

### Claim 66

A system for the detection of molecular interactions, comprising
a) a solid support comprising an array of etched microchannels, said solid support further comprising an array of target nucleic acid sequences; and
b) a first fusion protein comprising a DNA binding domain fused to a first binding partner, wherein said DNA binding domain is capable of binding to said target nucleic acid sequence; and
c) a second fusion protein comprising an RNA polymerase activation domain fused to a second binding partner, wherein said second binding partner is capable of interacting with said first binding partner.

### Claim 67

A system for the detection of molecular interactions, comprising:
a) a solution of at least one target nucleic acid sequence; and
b) a first fusion protein comprising a DNA binding domain fused to a first binding partner, wherein said DNA binding domain is capable of binding to said target nucleic acid sequence; and
c) a second fusion protein comprising an RNA polymerase activation domain fused to a second binding partner, wherein said second binding partner is capable of interacting with said first binding partner.

### Claim 68

A method of detecting interactions between biological molecules, comprising:
a) providing
i) a solid support comprising an array of target nucleic acid sequences; and
ii) a first protein capable of interacting with said target nucleic acid sequence;
iii) a second protein capable of interacting with said protein; and
iv) a system configured for the detection of RNA transcribed from said target nucleic acid sequences; and
b) contacting said first and second fusion proteins with said solid support under conditions such that said first and second proteins are capable of interacting;
c) detecting the presence or absence of RNA transcribed from said target nucleic acid sequence with said system, wherein said presence of said RNA is the result of an interaction between said first and second proteins.

### Claim 69 (depends on 68)

The method of claim 68, wherein said first protein comprises a first fusion protein comprising a DNA binding domain fused to a first binding partner, wherein said DNA binding domain is capable of binding to said target nucleic acid sequence.

### Claim 70 (depends on 68)

The method of claim 68, wherein said first protein comprises a second fusion protein comprising an RNA polymerase activation domain fused to a second binding partner, wherein said second binding partner is capable of interacting with said first binding partner.

### Claim 71 (depends on 68)

The method of claim 68, wherein said detection system is selected from the group consisting of a fluorescence detection system, a SPR detection system, a RT-PCR detection system, an electrophoresis detection system, and a hybridization detection system.

### Claim 72 (depends on 68)

The method of claim 68, wherein said solid support is a metal surface.

### Claim 73 (depends on 72)

The method of claim 72, wherein said metal surface is deposited on an SPR prism.

### Claim 74 (depends on 68)

The method of claim 68, wherein said array of target nucleic acid sequences comprises at least 20 distinct nucleic acid sequences.

### Claim 75 (depends on 68)

The method of claim 68, wherein said array of target nucleic acid sequences comprises at least 50 distinct nucleic acid sequences.

### Claim 76 (depends on 68)

The method of claim 68, wherein said array of target nucleic acid sequences comprises at least 100 distinct nucleic acid sequences.

### Claim 77 (depends on 68)

The method of claim 68, wherein said array of target nucleic acid sequences comprises at least 1000 distinct nucleic acid sequences.

### Claim 78 (depends on 68)

The method of claim 68, further comprising a plurality of first fusion proteins, wherein each of said plurality of fusion proteins comprises a distinct first binding partner.

### Claim 79 (depends on 68)

The method of claim 68, further comprising a plurality of second fusion proteins, wherein each of said plurality of fusion proteins comprises a distinct second binding partner.

### Claim 80 (depends on 68)

The method of claim 68, wherein said solid support further comprises a plurality of microfluidics channels.

### Claim 81 (depends on 68)

The method of claim 68, wherein said first binding partner is selected from the group consisting of a peptide, a polypeptide, a nucleic acid, a carbohydrate, a lipid and a small molecule.

### Claim 82 (depends on 68)

The method of claim 68, wherein said second binding partner is selected from the group consisting of a peptide, a polypeptide, a nucleic acid, a carbohydrate, a lipid and a small molecule.

### Claim 83

A method of detecting interactions between biological molecules, comprising:
a) providing
i) a solid support comprising a plurality of microfluidic channels, said solid support further comprising an array of target nucleic acid sequences; and
ii) a first protein capable of interacting with said target nucleic acid sequence;
iii) a second protein capable of interacting with said protein; and
iv) a system configured for the detection of RNA transcribed from said target nucleic acid sequences; and
b) contacting said first and second fusion proteins with said solid support under conditions such that said first and second proteins are capable of interacting;
c) detecting the presence or absence of RNA transcribed from said target nucleic acid sequence with said system, wherein said presence of said RNA is the result of an interaction between said first and second proteins.

### Claim 84

A method of detecting interactions between biological molecules, comprising:
a) providing
i) a solid support comprising a plurality of etched microchannels, said solid support further comprising an array of target nucleic acid sequences; and
ii) a first protein capable of interacting with said target nucleic acid sequence;
iii) a second protein capable of interacting with said protein; and
iv) a system configured for the detection of RNA transcribed from said target nucleic acid sequences; and
b) contacting said first and second fusion proteins with said solid support under conditions such that said first and second proteins are capable of interacting;
c) detecting the presence or absence of RNA transcribed from said target nucleic acid sequence with said system, wherein said presence of said RNA is the result of an interaction between said first and second proteins.

### Claim 85

A method of detecting interactions between biological molecules, comprising:
a) providing
i) a solid support comprising an array of target nucleic acid sequences; and
ii) a first protein capable of interacting with said target nucleic acid sequence;
iii) a second protein capable of interacting with said protein; and
iv) a system configured for the label-free detection of RNA transcribed from said target nucleic acid sequences; and
b) contacting said first and second fusion proteins with said solid support under conditions such that said first and second proteins are capable of interacting;
c) detecting the presence or absence of RNA transcribed from said target nucleic acid sequence with said system, wherein said presence of said RNA is the result of an interaction between said first and second proteins.

### Claim 86

A method of detecting molecular interactions, comprising:
a) providing
i) a solid surface comprising an array of first proteins;
ii) at least one second protein;
iii) a system configured for detecting an interaction of said first protein and said second protein; and
b) contacting said second proteins with said first protein array under conditions such that said first and second proteins are capable of interacting;
c) detecting said interaction of said first protein and said second protein using said system.

### Claim 87

A method of detecting molecular interactions, comprising:
a) providing
i) a surface comprising an array of first proteins;
ii) at least one second protein, said second protein comprising an epitope for an antibody;
iii) an antibody;
iv) a system configured for detecting an interaction of said second protein and said antibody; and
b) contacting said second protein with said first protein array under conditions such that said first and second proteins are capable of interacting;
c) contacting said antibody with said second protein; and
d) detecting the interaction of said second protein and said antibody using said system.

### Claim 88

A method of detecting molecular interactions, comprising:
a) providing
i) a solid surface comprising an array of target nucleic acids;
ii) at least one first protein;
iii) at least one second protein, said second protein further comprising an epitope for an antibody;
iv) at least one antibody; and
v) a system configured for detecting an interaction of said second protein and said antibody; and
b) contacting said first protein and said second protein under conditions such that said first and second proteins are capable of interacting;
c) contacting said interacting first and second proteins with said arrayed nucleic acids;
d) contacting said at least one antibody with said second protein; and
e) detecting the interaction of said first protein and said second protein using said apparatus.

### Claim 89

A method of detecting interactions between biological molecules, comprising:
a) providing
i) at least one target nucleic acid sequence in solution; and
ii) a first protein capable of interacting with said target nucleic acid sequence;
iii) a second protein capable of interacting with said protein; and
iv) a system configured for the detection of RNA transcribed from said target nucleic acid sequences, wherein said system comprises a solid support configured for the detection of said RNA transcribed from said target nucleic acid sequence; and
b) contacting said first and second fusion proteins with said target nucleic acid solution under conditions such that said first and second proteins are capable of interacting;
c) detecting the presence or absence of RNA transcribed from said target nucleic acid sequence with said system, wherein said presence of said RNA is the result of an interaction between said first and second proteins.

### Claim 90

A method of screening compounds, comprising:
a) providing
i) a solid support comprising an array of target nucleic acid sequences; and
ii) a first fusion protein comprising a first binding partner fused to a DNA binding domain, wherein said DNA binding domain is capable of binding to said target nucleic acid sequence;
iii) a second fusion protein comprising an RNA polymerase activation domain fused to a second binding partner, wherein said second binding partner is capable of interacting with said first binding partner;
iv) a system configured for the detection of RNA transcribed from said target nucleic acid sequences; and
v) at least one test compound; and
b) contacting said test compound, and said first and second fusion proteins with said solid support under conditions such that said first and second binding partners are capable of interacting;
c) detecting the presence or absence of RNA transcribed from said target nucleic acid sequence using said system, wherein the presence of said RNA is the result of an interaction between said first and second binding partners.

### Claim 91 (depends on 90)

The method of claim 90, further comprising the step of comparing the level of RNA transcribed from said target nucleic acid sequence in the presence of said test compound to the level of transcription in the absence of said test compound.

### Claim 92 (depends on 90)

The method of claim 90, wherein said test compound is a drug.

### Claim 93 (depends on 90)

The method of claim 90, wherein said detection system is selected from the group consisting of a fluorescence detection system, a SPR detection system, a RT-PCR detection system, an electrophoresis detection system, and a hybridization detection system.

### Claim 94 (depends on 90)

The method of claim 90, wherein said solid support is a metal surface.

### Claim 95

A method of screening compounds, comprising:
a) providing
i) a solid support comprising a array of first proteins;
ii) at least one second protein, wherein said second protein is capable of interacting with said first protein;
iii) at least one target nucleic acid sequence, wherein said target nucleic acid sequence is capable of interacting with said array of first proteins; and
iv) a system configured for the detection of RNA transcribed from said target nucleic acid sequences; and
v) at least one test compound; and
b) contacting said test compound, and said first and second fusion proteins with said solid support under conditions such that said first and second binding partners are capable of interacting;
c) detecting the presence or absence of RNA transcribed from said target nucleic acid sequence using said system, wherein the presence of said RNA is the result of an interaction between said first and second binding partners.
